Targeting Anti-Cancer Agents and Cancer Treatments

被引:0
|
作者
Sun, Lichun [1 ,2 ]
机构
[1] Fudan Univ, Peoples Hosp Shanghai 5, Dept Pharm, Shanghai 200240, Peoples R China
[2] Tulane Hlth Sci Ctr, Peptide Res Labs, Dept Med, New Orleans, LA 70112 USA
关键词
TYROSINE-KINASE INHIBITORS; SOMATOSTATIN; PATHWAY; ANALOGS; GROWTH; METABOLISM; GENERATION; ANTIBODIES; RECEPTORS; THERAPY;
D O I
10.2174/187152061507150713101049
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:806 / 808
页数:3
相关论文
共 50 条
  • [41] Bradykinin antagonists as anti-cancer agents
    Stewart, JM
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (25) : 2036 - 2042
  • [42] Antibodies and their fragments as anti-cancer agents
    Schaedel, O
    Reiter, Y
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (03) : 363 - 378
  • [43] Reengineered tricyclic anti-cancer agents
    Kastrinsky, David B.
    Sangodkar, Jaya
    Zaware, Nilesh
    Izadmehr, Sudeh
    Dhawan, Neil S.
    Narla, Goutham
    Ohlmeyer, Michael
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (19) : 6528 - 6534
  • [44] SYNTHESIS OF POTENTIAL ANTI-CANCER AGENTS
    SINGH, NN
    SINGH, B
    SINGH, GP
    SINGH, PN
    PATNA, PU
    HETEROCYCLES, 1984, 21 : 440 - 440
  • [45] Nephrotoxicity of recent anti-cancer agents
    Lameire, Norbert
    CLINICAL KIDNEY JOURNAL, 2014, 7 (01): : 11 - 22
  • [46] Rebeccamycin analogues as anti-cancer agents
    Prudhomme, M
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (02) : 123 - 140
  • [47] Anti-Cancer Agents in Medicinal Chemistry
    Das, Biswajit
    Kundu, Chanakya N.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021, 21 (04) : 416 - 427
  • [48] POTENTIAL ANTI-CANCER AGENTS - ANTI-CANCER INDOLE ALKALOIDS OF ERVATAMIA-HEYNEANA
    GUNASEKERA, SP
    CORDELL, GA
    FARNSWORTH, NR
    PHYTOCHEMISTRY, 1980, 19 (06) : 1213 - 1218
  • [49] Plants as a source of anti-cancer agents
    Cragg, GM
    Newman, DJ
    JOURNAL OF ETHNOPHARMACOLOGY, 2005, 100 (1-2) : 72 - 79
  • [50] Proteasome inhibitors as anti-cancer agents
    Murray, RZ
    Norbury, C
    ANTI-CANCER DRUGS, 2000, 11 (06) : 407 - 417